NCT03504852
- Conditions
- Body Weight, Moderate to Severe Chronic Plaque-Type Psoriasis, Pathological Conditions, Anatomical, +9 more
- Locations
-
- Novartis Investigative Site Birmingham, Alabama, United States
- Novartis Investigative Site Phoenix, Arizona, United States
- Novartis Investigative Site Rogers, Arkansas, United States
- Novartis Investigative Site Irvine, California, United States